Biography

1.Research Interest

Basic and clinical research on hypertension and coronary heart disease

The basic and clinical study on the treatment of hypertension, heart failure and metabolic syndrome by renal sympathetic denervation

2.Educational Background

1984-1989 Bachelor of Clinical Medicine, Harbin Medical University

1991-1994 Shantou University Medical College, Master

2002-2005 The West China College of Medicine, Sichuan University, Ph.D.

3.Work Experience

1994-1997 First Affiliated Hospital of Shantou University Medical College Cardiovascular Department

1997-1998 Visiting Scholar, Department of Cardiology, Queen Mary Hospital, Hong Kong University

2000-2001 Stanford University Cardiovascular Center Visiting Scholar

2004-now Department of Cardiology, Tianjin First Central Hospital, Director of cardiology department

4.Awards

expert who enjoys the special subsidy of the State Council.

A good doctor satisfied by the people of Tianjin

Outstanding Communist Party Member of Tianjin

The basic research of percutaneous renal denervation for the treatment of hypertension won the second prize of Tianjin Science and Technology Progress Award

Achievements

Vice Chairman of the Cardiovascular Branch of Tianjin Medical Association

Deputy Director of the Hypertension Professional Committee of Tianjin Medical Association

Vice President, Cardiovascular Physician Branch, Tianjin Medical Association

Chairman of the Cardiac Rehabilitation Committee of the Cross-Strait Medical and Health Exchange Association

Executive Director of Tianjin Heart Association

Peer-Reviewed Journal Papers

[1]Wang L, Song l, Li C, et al. Renal denervation improves cardiac function by attenuating myocardiocyte apoptosis in dogs after myocardial infarction. BMC Cardiovasc Disord,2018,18(1):86. Corresponding author.

[2] Li C, Wang L, Li Z,et al. Effcacy and safety of catheter-based renal sympathetic

denervation in treatment of chronic heart failure. Int J Clin Exp Med 2018;11(7):7319-7325. Corresponding author.

[3]Wang L, Wei G, Song L, et al. Effect of renal sympathetic denervation on ventricular and neural remodeling.Herz,2018. Corresponding author.

[4]He Q, Wang CM, Qin JY, et al. Effect of miR-203 expression on myocardial fibrosis. Eur Rev Med Pharmacol Sci. 2017,21(4):837-842. Corresponding author.

[5]Feng Q, Lu C, Wang L, et al. Effects of renal denervation on cardiac oxidative stress and local activity of the sympathetic nervous system and renin-angiotensin system in acute myocardial infracted dogs[J].BMC Cardiovasc Disord,2017,17(1):65.

First author and Corresponding author.

[6]Wang YX, Song L, Xing AJ, et al. Predictive Value of Cumulative Blood Pressure for All-Cause Mortality and Cardiovascular Events. Sci Rep. 2017, 7:41969. Corresponding author.

[7]Zhao HY, Liu XX, Wang AX, et al. Ideal cardiovascular health and incident hypertension: The longitudinal community-based Kailuan study. Medicine (Baltimore). 2016,95(50):e5415. Corresponding author.

[8]Jian L, Lu Y, Lu S, et al. Chemical chaperone 4-phenylbutyric acid protects H9c2 cardiomyocytes from ischemia/reperfusion injury by attenuating endoplasmic reticulum stress-induced apoptosis. Mol Med Rep. 2016,13(5):4386-92. 通讯作者。

[9]Luo Di，Zhang Xin ，LUChengzhi*.renal sympathetic denervation for the treatment of resistant hypertension with chronic renal failure : first -in-man experience.Chin Med J.2013;126(7):1392-1393. Corresponding author.

[10]Liu Y，Chen X, Lu Cz，et al. A case of intermittent high degree atrioventricular block during renal denervation，Chin J Cardiac.2014，18（3）：234-235. Corresponding author.

[11] Wang L, Lu CZ, Zhang X, Luo D, Zhao B, Yu X, Xia DS, Chen X, Zhao XD. The effect of catheter-based renal sympathetic denervation on renin-angiotensin-aldosterone system in patients with resistant hypertension. Zhong hua Xin Xue Guan Bing Za Zhi.2013;41(1):3-7. Corresponding author.

[12]Wang L, Lu CZ, Ma YJ, et al.Effect of renal sympathetic denervation on hypothalamus MAPK and NFκB in spontaneously hypertensive rats. 2018，26（1），36-40. Corresponding author.

[13]WANG L, Lu CZ, Zhang X, et al. Clinical study of percutaneously renal sympathetic denervation in the treatment of resistant hypertension .zhonghua gao xue ya za zhi;2013，21（5），436-440. Corresponding author.

Projects

1.The basic research of percutaneous renal sympathetic denervation for the treatment of hypertension

Tianjin Health and Family Planning Committee Key Project, Project Leader

In 2014, the Tianjin Health and Family Planning Committee identified the scientific and technological achievements as the leading level in China.

2.Effect of renal sympathetic denervation on cardiac function and remodeling factor in myocardial infarction dogs

Tianjin Application Foundation and Advanced Technology Research Program,2014-2017, Project Leader

3. The central mechanism and clinical study of RDN in the treatment of heart failure

Tianjin Municipal Health Planning Commission project ,Research Project Leader

4. Study on the protective mechanism of remote ischemic preconditioning for elderly NSTMI contrast nephropathy

Beijing Lisheng Cardiovascular Health Foundation, project leader